Altium Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-850,000
| Closed | -$3.57M | – | 107 |
|
|
2023
Q1 | $3.57M | Buy |
850,000
+400,000
| +89% | +$1.68M | 1.98% | 17 |
|
|
2022
Q4 | $2.7M | Buy |
450,000
+23,000
| +5% | +$138K | 1.37% | 29 |
|
|
2022
Q3 | $2.49M | Buy |
+427,000
| New | +$2.49M | 0.91% | 42 |
|
|
2022
Q2 | – | Sell |
-299,800
| Closed | -$1.4M | – | 145 |
|
|
2022
Q1 | $1.4M | Sell |
299,800
-1,885,200
| -86% | -$8.8M | 0.47% | 67 |
|
|
2021
Q4 | $5.42M | Sell |
2,185,000
-1,128,000
| -34% | -$2.8M | 1.49% | 17 |
|
|
2021
Q3 | $9.77M | Sell |
3,313,000
-365,677
| -10% | -$1.08M | 2.56% | 4 |
|
|
2021
Q2 | $9.2M | Buy |
3,678,677
+3,089,685
| +525% | +$7.72M | 2.13% | 6 |
|
|
2021
Q1 | $1.71M | Hold |
588,992
| – | – | 0.48% | 88 |
|
|
2020
Q4 | $1.9M | Buy |
+588,992
| New | +$1.9M | 0.71% | 67 |
|